The aggregate purchase price of the Shaw Acquisition is $129,500 and will be paid through issuance of 350,000 common shares of the Company at a deemed issuance price of $0.28 per JUMP Share and 350,000 non-transferable common share purchase warrants of the Company.Įach JUMP Warrant entitles the holder to purchase one common share of the Company at an exercise price of $0.30 per share prior to December 31, 2023. (TSXV: JUMP) (OTCQB: JMPHF), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has acquired 23.8% of the issued and outstanding shares of each of Shaw Vision Inc. (NASDAQ:EYE), EssilorLuxottica SA (OTC:ESLOY), Alcon Inc. (TSXV:JUMP)(OTC:JMPHF), National Vision Holdings Inc. In fact, some of us deal with what’s known as Aniseikonia, or as noted by Clinical and Experimental Optometry “is a difference in the perceived size or shape of images between eyes, and can arise from a variety of physiological, neurological, retinal, and optical causes.” In fact, as many as “20-30% of the general spectacle wearing population may have a measurable amount of aniseikonia,” as noted by the Columbia University Department of Ophthalmology, which added, “Symptoms can include headaches, double vision, disorientation or dizziness, tearing, eye pain or fatigue, sensitivity to light, visual acuity issues and trouble reading, as well as nausea.” While Aniseikonia can be a real headache, companies are racing to help, including Leveljump Healthcare Corp. Unfortunately, for some of us, we don’t have the best vision. Of your five senses, eye sight ranks up there as most important, and essential.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |